Skip to content

Add cell line disease curation guidance to preclinical evidence docs#173

Open
obigriffith wants to merge 1 commit into
masterfrom
cell-line-disease-curation-docs
Open

Add cell line disease curation guidance to preclinical evidence docs#173
obigriffith wants to merge 1 commit into
masterfrom
cell-line-disease-curation-docs

Conversation

@obigriffith

Copy link
Copy Markdown
Contributor

Expands D-Level Curation Practices in level.rst to clarify that disease selection for in vitro cell line evidence should reflect study context and author intent rather than the literal cancer type of the cell line used. Adds contrasting EID39 (neuroblastoma/Ba/F3) and EID1356 (multi-cancer/Ba/F3) examples. Adds a cross-reference pointer in disease.rst and fixes a broken URL on the CIViC Disease Page link.

Expands D-Level Curation Practices in level.rst to clarify that disease
selection for in vitro cell line evidence should reflect study context and
author intent rather than the literal cancer type of the cell line used.
Adds contrasting EID39 (neuroblastoma/Ba/F3) and EID1356 (multi-cancer/Ba/F3)
examples. Adds a cross-reference pointer in disease.rst and fixes a broken
URL on the CIViC Disease Page link.

Co-Authored-By: Claude Sonnet 4.6 <noreply@anthropic.com>
Comment on lines +168 to +170
For example, `EID39 <https://civicdb.org/links/evidence/39>`__ describes a study in which ALK mutations were identified in neuroblastoma patient samples and neuroblastoma cell lines. The authors subsequently confirmed sensitivity of these mutations to an ALK inhibitor using Ba/F3 cells — a generic murine pro-B cell model with no inherent connection to neuroblastoma. Despite the use of Ba/F3 cells for the functional experiment, the disease context of the study is neuroblastoma and the authors' conclusions relate to therapeutic implications for neuroblastoma patients. The appropriate disease field for this evidence item is therefore “Neuroblastoma” rather than “cancer” or a hematologic malignancy.

In contrast, `EID1356 <https://civicdb.org/links/evidence/1356>`__ describes preclinical work also performed in Ba/F3 cells, but with conclusions that were intended to apply broadly across multiple cancer subtypes. In this case “Cancer” is the appropriate disease selection. When a study lacks a clear disease-specific context, or the authors' conclusions are explicitly intended to apply broadly, it remains appropriate to assign “cancer” or the literal disease of the cell line.

Copy link
Copy Markdown
Member

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

The quoted term "Neuroblastoma" is capitalized and "Cancer" is capitalized once in these two sections, but it appears as "cancer" the other two times it appears. Probably all should be made consistent with how they'll appear in the UI.

Copy link
Copy Markdown
Contributor Author

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

This is fair. I believe they are both capitalized in the UI and therefore when quoted should be capitalized.

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment

Labels

None yet

Projects

None yet

Development

Successfully merging this pull request may close these issues.

2 participants